DESIGN AND EVALUATION OF HYDRALAZINE HYDROCHLORIDE MOUTH DISSOLVING TABLET FOR THE MANAGEMENT OF HYPERTENSION

S. Muthukumar, R. Sundaraganapathy
{"title":"DESIGN AND EVALUATION OF HYDRALAZINE HYDROCHLORIDE MOUTH DISSOLVING TABLET FOR THE MANAGEMENT OF HYPERTENSION","authors":"S. Muthukumar, R. Sundaraganapathy","doi":"10.24327/ijrsr.2017.0805.0310","DOIUrl":null,"url":null,"abstract":"Eclampsia and preeclampsia is an acute and life threatening complication during pregnancy.Hydralazine hydrochloride is one of the drugs of choice in treating this condition The purpose of the present research work was to formulate the orodispersible tablets by using different methods and provide a suitable patient convenience dosage form to enhance the bioavailability and provide quick onset of action. Formulation of orodispersible tablets of Hydralazine hydrochloride were prepared by using various superdisintegrants like crosspovidone, cross caramellose sodium and sodium starch glycolate by direct compression method and camphor as an excipient by sublimation technique. The formulas were evaluated for compatibility and Precompressional studies. The formulations were evaluated for weight variation, thickness, hardness, friability, content uniformity, disintegration time, wetting time, water absorption ratio and release profile. Among all the formulations F9 and SF9 showed effective percentage of drug release at 12 minutes indicating faster and maximum absorption at the site of administration.","PeriodicalId":14198,"journal":{"name":"International journal of recent scientific research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of recent scientific research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24327/ijrsr.2017.0805.0310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Eclampsia and preeclampsia is an acute and life threatening complication during pregnancy.Hydralazine hydrochloride is one of the drugs of choice in treating this condition The purpose of the present research work was to formulate the orodispersible tablets by using different methods and provide a suitable patient convenience dosage form to enhance the bioavailability and provide quick onset of action. Formulation of orodispersible tablets of Hydralazine hydrochloride were prepared by using various superdisintegrants like crosspovidone, cross caramellose sodium and sodium starch glycolate by direct compression method and camphor as an excipient by sublimation technique. The formulas were evaluated for compatibility and Precompressional studies. The formulations were evaluated for weight variation, thickness, hardness, friability, content uniformity, disintegration time, wetting time, water absorption ratio and release profile. Among all the formulations F9 and SF9 showed effective percentage of drug release at 12 minutes indicating faster and maximum absorption at the site of administration.
盐酸肼嗪口腔溶片治疗高血压的设计与评价
子痫和先兆子痫是一种急性和危及生命的并发症在怀孕期间。盐酸海达拉嗪是治疗此病的首选药物之一,本研究的目的是通过不同的方法制备口服分散片,并提供适合患者的方便剂型,以提高生物利用度和快速起效。以交叉聚维酮、交叉焦糖钠、乙醇酸淀粉钠等多种超崩解剂为原料,采用直接压缩法,以樟脑为辅料,升华法制备盐酸羟丙嗪口腔分散片。评估了配方的相容性和预压缩研究。对配方的重量变化、厚度、硬度、脆性、含量均匀性、崩解时间、润湿时间、吸水率和释放度进行了评价。其中F9和SF9在12分钟的有效释药率表明给药部位吸收更快,吸收最大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信